Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
June 15 2021 - 04:35PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934.
Commission File
Number:000-5463
PREMIER
BIOMEDICAL, INC.
(Exact name of registrant as specified in its charter)
507
River Lakes Parkway
Whitefish, Montana
59937-7803
(312)
718--9393
(Address, including zip code, and telephone number, including area
code,
of registrant’s principal executive offices)
Common
(Title of each class of securities covered by this
Form)
None
(Titles of all other classes of securities for which a duty to file
reports
under section 13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file
reports:
Rule 12g-4(a)(1)
|
☐ |
|
|
|
|
Rule 12g-4(a)(2)
|
☐ |
|
|
|
|
Rule 12h-3(b)(1)(i)
|
☐ |
|
|
|
|
Rule 12h-3(b)(1)(ii)
|
☐ |
|
|
|
|
Rule 15d-6
|
☒ |
|
|
|
|
Rule
15d-22(b)
|
☐ |
|
Approximate number
of holders of record as of the certification or notice date:
122.
Pursuant to the
requirements of the Securities Exchange Act of 1934 [Name of registrant as specified in
charter] has caused this certification/notice to be signed
on its behalf by the undersigned duly authorized
person.
Date:
|
By:
|
/s/
John Maddox
|
|
|
John
Maddox, President
|
|
|
|
Premier Biomedical (PK) (USOTC:BIEI)
Historical Stock Chart
From Jun 2022 to Jul 2022
Premier Biomedical (PK) (USOTC:BIEI)
Historical Stock Chart
From Jul 2021 to Jul 2022